{"id":937736,"date":"2026-02-18T07:07:40","date_gmt":"2026-02-18T12:07:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/"},"modified":"2026-02-18T07:07:40","modified_gmt":"2026-02-18T12:07:40","slug":"immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/","title":{"rendered":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025<\/p>\n<p align=\"justify\">(OXFORDSHIRE, England &amp; RADNOR, Penn. &amp; GAITHERSBURG, Md., US, 18 February 2026) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eQUE_E3hbnYC1-ultj3YVnBVq6o_kRufJvbKkpylE-rlVXxsoSlR2_fHV8ZQxP44qb5Oonp43CNEISSASz2XrxUxxXnAgkCA-XVDWzYJYd8lnICWXoIM6SsNFTNle8F8_lqIWSwF3Bie6QLcAPFFpHDaJ9G0wuknvB93I_hSzTEFh5Md23itUkADo6xCNXuk\" rel=\"nofollow\" target=\"_blank\">Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)<\/a>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Wednesday, February 25, 2026.<\/p>\n<p align=\"justify\">Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST (1:00 p.m. GMT) to discuss its financial results and provide a business and portfolio update.<\/p>\n<p align=\"justify\">\n        <b>Audio Webcast<\/b><br \/>\n        <br \/>The call will be webcast live and can be accessed by visiting \u2018Events\u2019, under \u2018Events and Presentations\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay will also be made available for a limited time.<\/p>\n<p align=\"justify\">\n        <b>Conference Call Details:<\/b><br \/>\n        <br \/>Domestic (toll-free): 877-405-1239<br \/>International (toll): +1 201-389-0851<\/p>\n<p align=\"justify\">\n        <b>About Immunocore<\/b>\n      <\/p>\n<p align=\"justify\">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs\u200b in oncology, infectious diseases, and autoimmune diseases. The Company\u2019s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.<\/p>\n<p align=\"justify\">\n        <b>Contact Information<\/b>\n      <\/p>\n<p align=\"justify\">\n        <b>Immunocore <\/b>\n      <\/p>\n<p align=\"justify\">S\u00e9bastien Desprez, Head of Communications<br \/>T: +44 (0) 7458030732<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4zZtylRp7dwJItK8zsrUzjJeDKSYxRlFBz-vCX4UpDjte7OfQ1n2deD0e_x2zpnN9DTtkPG1aGPxhnZUB8s9EAmQzGbovV1dtUTsxBWXjb0AVxgRyxMKUlCUct_wOUHx1wDjDfXjBRKcPf4Y_v_I_Q==\" rel=\"nofollow\" target=\"_blank\"><u>sebastien.desprez@immunocore.com<\/u><\/a><br \/>Follow on LinkedIn: @Immunocore<\/p>\n<p align=\"justify\">\n        <b>Investor Relations<\/b>\n      <\/p>\n<p align=\"justify\">Clayton Robertson \/ Morgan Morse<br \/>T: +1 (215) 384-4781<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zntp6LFi6h_DsLYcpZMQkmaPeKE7aTliU6jw1CFY1sX3KhGABaPV-EFqXrRQPqmMMYA3Q11RGVfOmlqImOBNXD9MpN2sqGUDRf5qWOBlqcE=\" rel=\"nofollow\" target=\"_blank\"><u>ir@immunocore.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzY2ODQ4ZjMtMzI3OC00MThjLWFhOWYtYzE5MmQ5Zjk3MGZkLTEyMTc4MTEtMjAyNi0wMi0xOC1lbg==\/tiny\/Immunocore-Holdings-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 (OXFORDSHIRE, England &amp; RADNOR, Penn. &amp; GAITHERSBURG, Md., US, 18 February 2026) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Wednesday, February 25, 2026. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST (1:00 p.m. GMT) to discuss its financial results and provide a business and portfolio update. Audio Webcast The call &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-937736","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 (OXFORDSHIRE, England &amp; RADNOR, Penn. &amp; GAITHERSBURG, Md., US, 18 February 2026) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Wednesday, February 25, 2026. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST (1:00 p.m. GMT) to discuss its financial results and provide a business and portfolio update. Audio Webcast The call &hellip; Continue reading &quot;Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-18T12:07:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025\",\"datePublished\":\"2026-02-18T12:07:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/\",\"name\":\"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\",\"datePublished\":\"2026-02-18T12:07:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/","og_locale":"en_US","og_type":"article","og_title":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk","og_description":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 (OXFORDSHIRE, England &amp; RADNOR, Penn. &amp; GAITHERSBURG, Md., US, 18 February 2026) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Wednesday, February 25, 2026. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST (1:00 p.m. GMT) to discuss its financial results and provide a business and portfolio update. Audio Webcast The call &hellip; Continue reading \"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-18T12:07:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025","datePublished":"2026-02-18T12:07:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/","name":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==","datePublished":"2026-02-18T12:07:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTI2MCM0MDIzMzQyODUjMjIwNjI1OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-call-on-february-25-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=937736"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937736\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=937736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=937736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=937736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}